I really think Opexa should do some press release to Neurologists around the world, as its starting to bug me that they dont know about it. When I bring it up it must sound like some hair brained treatment, as I have a history of trying most treatments out there.
I tend to agree with you because although Opexa announced reaching the halfway point in recruitment recently, I've got reason to believe coming up with another 75 people is going to be harder and more time consuming.
I realize that entering this clinical trial requires taking the chance that you'll be on placebo and "unprotected" for a year, there is also good reason to believe that the "protection" provided by the crabs is providing false security.
Considering it's estimated that there are 400,000 people inflicted with MS in the US it seems terribly ironic to me that the Tovaxin clinical trial wouldn't have people falling over each other to enroll and to the contrary they're going to have a hard time coming up with 150 for something which doesn't seem to have negative side effects and seemingly is 100% effective?
I'm not sure of the rules that Opexa has to abide by. Maybe going out of their way to advertise the clinical trial is against the rules. My wife took one of the Opexa flyers regarding the clinical trial and is sending it to her neuros because they also said that they weren't familar with Tovaxin. Hopefully they will post them where their patients will see them....but I doubt it.
Regardless of how safe and effective a treatment proves to be, it's going to be nearly impossible to gain any headway against the existing infrastructure of the crabs which is already in place.
Something isn't right about this picture.